Equity Profile

SOLV

Solventum Corporation

Health CareHealth Care Supplies$13.4B

May5Tue

Post-Earnings Recap

ReportedQ1-2026After Close4:05 PM EDT

Solventum Corporation Beats on EPS, Stock Up 2.37%

Metric	Actual	Expected	Surprise
EPS	$1.48	$1.35	+9.39%
Revenue	N/A	$2.0B	N/A

management commentary, guidance changes, and full analysis available with Pro.

Solventum Corporation Beats on EPS, Stock Up 2.37%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$1.48	$1.35	+9.39%
Revenue	N/A	$2.0B	N/A

Management Commentary

Tone: Unknown

No transcript is on record, and the analysis is based solely on numerical results.

What It Means

Solventum Corporation reported better-than-expected earnings per share, which led to a positive stock reaction, rising 2.37%. However, the company did not provide revenue figures or guidance, leaving some uncertainty about future performance. Investors may view the EPS beat as a positive sign, but the lack of revenue data could raise questions about overall growth.

Company Snapshot

Solventum Corporation operates in the health care supplies sector, providing essential products that support medical facilities and patient care. With a market cap of $12 billion, the company plays a crucial role in the healthcare ecosystem, especially as demand for medical supplies continues to grow amidst ongoing health challenges.

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.

$1.35

Revenue

Total revenue reflects the overall sales performance of the company and is critical for assessing growth.

$2.0B

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+10.27%

Avg Stock Reaction

+1.14%

Last Quarter Recap

In Q4-2025, Solventum reported an EPS of $1.57, exceeding expectations by 4.67%. The stock reacted positively, increasing by 2.48% the following day.

Management Promises & Guidance

Continued focus on product innovation to meet market demands.
Commitment to maintaining high-quality standards in manufacturing.
Plans to expand distribution channels to reach more healthcare providers.

Expectations

Wall Street Expectations

Analysts expect Solventum to report solid earnings, with a consensus EPS of $1.35 and revenue of $2.0 billion. The market is looking for continued growth and strong performance.

Bull Case

If Solventum beats EPS estimates and demonstrates strong revenue growth, it could signal robust demand for its products, leading to a positive stock reaction.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it may raise concerns about its growth trajectory, leading to a negative market reaction.

Key Metrics to Watch

EPS

$1.35

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.

Revenue

$2.0B

Total revenue reflects the overall sales performance of the company and is critical for assessing growth.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Solventum achieve an EPS of $1.35 or higher?

A strong EPS result would reinforce investor confidence and could lead to a positive stock reaction.

What guidance will management provide regarding revenue growth?

Clear guidance on future revenue growth is crucial for assessing the company's ability to sustain its performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Solventum's ability to capitalize on increasing healthcare demand, particularly in specialized medical supplies.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating strong operational management.

Options pricing suggests a higher expected move than historical averages, indicating potential for a significant reaction.

Recent market trends show increased spending in healthcare, which could benefit Solventum.

Key Risk

If revenue growth comes in below $1.9 billion, it could undermine the bullish sentiment surrounding the stock.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be closely watched as it may indicate the company's ability to navigate market challenges.

Bull Confirmed If

An EPS of $1.40 or higher would confirm strong operational performance and investor confidence.

Bear Confirmed If

An EPS below $1.30 would raise concerns about profitability and growth potential.

Pre-Earnings Positioning

Options Market

Implied Move

±6.22%

Historical Avg

±2.1%

Pricing rich

The options market is pricing in a significant move, suggesting that traders anticipate volatility around the earnings announcement.

Options are pricing ±7.1% while SOLV has averaged ±2.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

28.5%

Calls (14K)P/C Ratio: 1.59Puts (22K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Solventum beats expectations, history suggests the stock could rise by an average of 0.54%, confirming strong demand and operational efficiency.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further clarity from management.

Miss

A miss could lead to a decline, with historical data suggesting an average drop of 2.06% following disappointing results.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Insights into supply chain management and cost control measures.
3Management's view on market demand trends and competitive positioning.
4Details on any strategic partnerships or collaborations in the pipeline.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

May4

GRABReported

Grab Holdings Limited

RecapView

May4

GBDCReported

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.

$1.35

Revenue

Total revenue reflects the overall sales performance of the company and is critical for assessing growth.

$2.0B

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+10.27%

Avg Stock Reaction

+1.14%

Last Quarter Recap

In Q4-2025, Solventum reported an EPS of $1.57, exceeding expectations by 4.67%. The stock reacted positively, increasing by 2.48% the following day.

Management Promises & Guidance

Continued focus on product innovation to meet market demands.
Commitment to maintaining high-quality standards in manufacturing.
Plans to expand distribution channels to reach more healthcare providers.

Expectations

Wall Street Expectations

Analysts expect Solventum to report solid earnings, with a consensus EPS of $1.35 and revenue of $2.0 billion. The market is looking for continued growth and strong performance.

Bull Case

If Solventum beats EPS estimates and demonstrates strong revenue growth, it could signal robust demand for its products, leading to a positive stock reaction.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it may raise concerns about its growth trajectory, leading to a negative market reaction.

Key Metrics to Watch

EPS

$1.35

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.

Revenue

$2.0B

Total revenue reflects the overall sales performance of the company and is critical for assessing growth.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Solventum achieve an EPS of $1.35 or higher?

A strong EPS result would reinforce investor confidence and could lead to a positive stock reaction.

What guidance will management provide regarding revenue growth?

Clear guidance on future revenue growth is crucial for assessing the company's ability to sustain its performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Solventum's ability to capitalize on increasing healthcare demand, particularly in specialized medical supplies.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating strong operational management.

Options pricing suggests a higher expected move than historical averages, indicating potential for a significant reaction.

Recent market trends show increased spending in healthcare, which could benefit Solventum.

Key Risk

If revenue growth comes in below $1.9 billion, it could undermine the bullish sentiment surrounding the stock.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be closely watched as it may indicate the company's ability to navigate market challenges.

Bull Confirmed If

An EPS of $1.40 or higher would confirm strong operational performance and investor confidence.

Bear Confirmed If

An EPS below $1.30 would raise concerns about profitability and growth potential.

Pre-Earnings Positioning

Options Market

Implied Move

±6.22%

Historical Avg

±2.1%

Pricing rich

The options market is pricing in a significant move, suggesting that traders anticipate volatility around the earnings announcement.

Options are pricing ±7.1% while SOLV has averaged ±2.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

28.5%

Calls (14K)P/C Ratio: 1.59Puts (22K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Solventum beats expectations, history suggests the stock could rise by an average of 0.54%, confirming strong demand and operational efficiency.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further clarity from management.

Miss

A miss could lead to a decline, with historical data suggesting an average drop of 2.06% following disappointing results.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Insights into supply chain management and cost control measures.
3Management's view on market demand trends and competitive positioning.
4Details on any strategic partnerships or collaborations in the pipeline.